A single-nucleotide polymorphism in a herpesvirus DNA polymerase is sufficient to cause lethal neurological disease.
暂无分享,去创建一个
[1] C. Carter,et al. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky. , 2008, Equine veterinary journal.
[2] J. Casanova,et al. Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans , 2007, Current opinion in allergy and clinical immunology.
[3] G. Palù,et al. A Point Mutation in a Herpesvirus Polymerase Determines Neuropathogenicity , 2007, PLoS pathogens.
[4] Eric T Baldwin,et al. Crystal Structure of the Herpes Simplex Virus 1 DNA Polymerase* , 2006, Journal of Biological Chemistry.
[5] R. Bowden,et al. Analysis of Equid Herpesvirus 1 Strain Variation Reveals a Point Mutation of the DNA Polymerase Strongly Associated with Neuropathogenic versus Nonneuropathogenic Disease Outbreaks , 2006, Journal of Virology.
[6] J. von Einem,et al. Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. , 2006, BioTechniques.
[7] J. von Einem,et al. Equine herpesvirus type 1 modified live virus vaccines: quo vaditis? , 2006, Expert review of vaccines.
[8] Andrew J Davison,et al. Evolution of the herpesviruses. , 2002, Veterinary microbiology.
[9] N. Osterrieder,et al. Equine herpesvirus type 1 devoid of gM and gp2 is severely impaired in virus egress but not direct cell-to-cell spread. , 2002, Virology.
[10] N. Osterrieder,et al. Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC). , 2002, Journal of veterinary medicine. B, Infectious diseases and veterinary public health.
[11] K. Tyler,et al. A herpes simplex virus DNA polymerase mutation that specifically attenuates neurovirulence in mice. , 1998, Virology.
[12] W. D. Wilson,et al. Equine herpesvirus 1 myeloencephalopathy. , 1997, The Veterinary clinics of North America. Equine practice.
[13] F. Lori,et al. Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Coen,et al. Engineered herpes simplex virus DNA polymerase point mutants: the most highly conserved region shared among alpha-like DNA polymerases is involved in substrate recognition , 1990, Journal of virology.
[15] P Argos,et al. An attempt to unify the structure of polymerases. , 1990, Protein engineering.
[16] M. Hunkapiller,et al. Human DNA polymerase alpha gene expression is cell proliferation dependent and its primary structure is similar to both prokaryotic and eukaryotic replicative DNA polymerases. , 1988, The EMBO journal.
[17] D. Coen,et al. Penciclovir and pathogenesis phenotypes of drug-resistant Herpes simplex virus mutants. , 1998, Antiviral research.
[18] Bryans Jt,et al. Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. , 1986 .